CN115135639B - 制备6-羧基苯并噁唑衍生物的有效方法 - Google Patents

制备6-羧基苯并噁唑衍生物的有效方法 Download PDF

Info

Publication number
CN115135639B
CN115135639B CN202080096991.1A CN202080096991A CN115135639B CN 115135639 B CN115135639 B CN 115135639B CN 202080096991 A CN202080096991 A CN 202080096991A CN 115135639 B CN115135639 B CN 115135639B
Authority
CN
China
Prior art keywords
formula
compound
dichlorophenyl
acid
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202080096991.1A
Other languages
English (en)
Chinese (zh)
Other versions
CN115135639A (zh
Inventor
S·P·柯伦
P·M·奥尼尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ireland Pharmaceuticals
Original Assignee
Pfizer Ireland Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ireland Pharmaceuticals filed Critical Pfizer Ireland Pharmaceuticals
Publication of CN115135639A publication Critical patent/CN115135639A/zh
Application granted granted Critical
Publication of CN115135639B publication Critical patent/CN115135639B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57Aryl or substituted aryl radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/423Oxazoles condensed with carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D317/34Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/18Bridged systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CN202080096991.1A 2019-12-20 2020-12-16 制备6-羧基苯并噁唑衍生物的有效方法 Active CN115135639B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962951691P 2019-12-20 2019-12-20
US62/951,691 2019-12-20
US202063120426P 2020-12-02 2020-12-02
US63/120,426 2020-12-02
PCT/IB2020/062040 WO2021124158A1 (en) 2019-12-20 2020-12-16 Efficient process for making 6-carboxy benzoxazole derivatives

Publications (2)

Publication Number Publication Date
CN115135639A CN115135639A (zh) 2022-09-30
CN115135639B true CN115135639B (zh) 2025-04-01

Family

ID=73856234

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080096991.1A Active CN115135639B (zh) 2019-12-20 2020-12-16 制备6-羧基苯并噁唑衍生物的有效方法

Country Status (14)

Country Link
US (1) US12410145B2 (https=)
EP (1) EP4077287B1 (https=)
JP (1) JP2023507399A (https=)
KR (1) KR20220114626A (https=)
CN (1) CN115135639B (https=)
AU (1) AU2020406455B2 (https=)
BR (1) BR112022012097A2 (https=)
CA (1) CA3165298A1 (https=)
ES (1) ES3055912T3 (https=)
HR (1) HRP20251570T1 (https=)
IL (1) IL294115A (https=)
MX (1) MX2022007787A (https=)
TW (1) TWI771827B (https=)
WO (1) WO2021124158A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4077287B1 (en) 2019-12-20 2025-11-19 Pfizer Ireland Pharmaceuticals Unlimited Company Efficient process for making 6-carboxy benzoxazole derivatives
KR102657823B1 (ko) * 2022-03-10 2024-04-16 고려대학교 산학협력단 타파미디스의 신규 합성법
US11970468B1 (en) 2023-10-23 2024-04-30 King Faisal University 2-(benzo[d]oxazol-2-yl)-N′-(3,5-dichlorobenzoyloxy)acetimidamide as an antimicrobial compound

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101413143A (zh) * 2002-12-19 2009-04-22 斯克里普斯研究学院 稳定甲状腺素运载蛋白和抑制甲状腺素运载蛋白错折叠的组合物和方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5222642A (en) 1975-08-14 1977-02-21 Kawasaki Heavy Ind Ltd Power generation device by hot water
GB8703975D0 (en) 1987-02-20 1987-03-25 Wellcome Found Pesticidal compounds
GB8809316D0 (en) * 1987-05-11 1988-05-25 Ici America Inc Heterocyclic ketones
JP5419545B2 (ja) 2009-05-25 2014-02-19 株式会社トクヤマ オルトエステル化合物の製造方法
US8168683B2 (en) 2009-10-15 2012-05-01 E. I. Du Pont De Nemours And Company Fluorinated vinylidene cationic surfactant
TWI550071B (zh) * 2011-03-25 2016-09-21 捷恩智股份有限公司 原酸酯化合物、液晶組成物及液晶顯示元件
RU2586330C2 (ru) * 2011-09-16 2016-06-10 Пфайзер Инк. Твердые формы ингибитора диссоциации транстиретина
US9499527B2 (en) * 2012-05-10 2016-11-22 Cellix Bio Private Limited Compositions and methods for the treatment of familial amyloid polyneuropathy
PT4349406T (pt) * 2014-09-08 2026-02-04 Pfizer Formas sólidas cristalinas de 6-carboxi-2-(3,5-diclorofenil)-benzoxazol para utilização como medicamento
CN107344927A (zh) * 2016-05-05 2017-11-14 苏州晶云药物科技有限公司 Tafamidis葡甲胺盐的晶型E及其制备方法和用途
US10766893B2 (en) * 2017-12-20 2020-09-08 H. Lundbeck A/S 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
EP4077287B1 (en) 2019-12-20 2025-11-19 Pfizer Ireland Pharmaceuticals Unlimited Company Efficient process for making 6-carboxy benzoxazole derivatives

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101413143A (zh) * 2002-12-19 2009-04-22 斯克里普斯研究学院 稳定甲状腺素运载蛋白和抑制甲状腺素运载蛋白错折叠的组合物和方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Benzoxazole and benzothiazole amides as novel pharmacokinetic enhancers of HIV protease inhibitors;Tim H. M. Jonckers,等;Bioorganic & Medicinal Chemistry Letters;20120616;第22卷(第15期);第5000页表1及第5001页Scheme1 *

Also Published As

Publication number Publication date
ES3055912T3 (en) 2026-02-16
AU2020406455B2 (en) 2024-02-15
TW202136222A (zh) 2021-10-01
EP4077287A1 (en) 2022-10-26
BR112022012097A2 (pt) 2022-08-30
JP2023507399A (ja) 2023-02-22
CN115135639A (zh) 2022-09-30
US20230090609A1 (en) 2023-03-23
EP4077287C0 (en) 2025-11-19
HRP20251570T1 (hr) 2026-01-30
WO2021124158A1 (en) 2021-06-24
EP4077287B1 (en) 2025-11-19
MX2022007787A (es) 2022-07-19
US12410145B2 (en) 2025-09-09
KR20220114626A (ko) 2022-08-17
TWI771827B (zh) 2022-07-21
IL294115A (en) 2022-08-01
AU2020406455A1 (en) 2022-07-14
CA3165298A1 (en) 2021-06-24

Similar Documents

Publication Publication Date Title
CN115135639B (zh) 制备6-羧基苯并噁唑衍生物的有效方法
JPH0751562B2 (ja) 4−置換1,4−ジヒドロピリジン類の新規製法
JPH0859514A (ja) 芳香族ホウ素化合物を芳香族ハロゲン化合物又はペルフルオロアルキルスルホネートと交差カップリングさせる方法
CA2855351A1 (en) Novel pyrrole derivatives
EA007965B1 (ru) Способ получения комбретастатинов
ES2655851T3 (es) Proceso para la preparación de un derivado de fluorolactona
NZ547354A (en) A process for resolving, optionally substituted, mandelic acids by salt formation with a chiral base cyclic amide
RU2810493C1 (ru) Эффективный процесс получения производных 6-карбоксибензоксазола
HK40075510A (en) Efficient process for making 6-carboxy benzoxazole derivatives
US3345416A (en) Preparation and rearrangement of beta-ketosulfoxides
EP1644313A2 (en) Process for the preparation and purification of 2-(alkoxyalkylidene)-3-ketoalkanoic acid esters from 3-ketoalkanoic acid esters
JPS596297B2 (ja) 新規アミドオキシム誘導体
CN104918924B (zh) 制备氟代内酯衍生物的方法
JPH0794446B2 (ja) 2−フエニルピリミジン誘導体
JP4070608B2 (ja) 光学的に活性なジヒドロピロンの製造方法
JP3856241B2 (ja) 1(2h)−キノリンカルボン酸の新規な誘導体、その合成方法及び抗生剤作用を有する化合物を合成するためのその使用方法
JPH0710822A (ja) アミノ酸エステルの光学異性体分離法
JPS6334153B2 (https=)
US3185712A (en) Alpha-keto-gamma-lactone derivatives
SU252330A1 (ru) Способ получения оксимов
JP2002363171A (ja) 4−置換−3−アミノイソオキサゾール誘導体の製法
JPH06179641A (ja) オキサゾリジノン形成による光学活性4−アミノ−1,3−ペンタンジオールの単離法
JPS6356233B2 (https=)
HU179944B (hu) Javított eljárás 2-/di- és triszubsztituált-fenil/-glicinek előállítására
JPH075549B2 (ja) オキシインドール誘導体の製造法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40075510

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant